Dendrimer-platinate: A novel approach to cancer chemotherapy

Anti-Cancer Drugs

Volumn 10, Issue 8, 1999, Pages 767-776

  Malik, Navid ^a   Evagorou, Evagoras G ^a   Duncan, Ruth ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dendrimer; EPR effect; HPMA copolymers; Platinate; Polymer therapeutics; Tumor targeting

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; DENDRIMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; LEUKEMIA L 1210; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033376651     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199909000-00010     Document Type: Article

References (31)

1. 1. Connors TA, New anti-cancer agents. Anti-Cancer Drugs 1996; 7: 179-85.
2. 2. Duncan R. Drug-polymer conjugates: potential for improved chemotherapy. Anti-Cancer Drugs 1992; 3: 175-210.
3. 3. Duncan R, Dimitrijevic S, Evagororou EG. The role of polymer conjugates in the diagnosis and treatment of cancer. STP Pharma Sci 1996; 6: 237-63.
4. 4. Brocchini S, Duncan R. Polymer drug conjugates: drug release from pendent linkers. In: Mathiowitz E, ed. Encyclopedia of controlled release. New York: Wiley 1999: 787-816.
5. 5. Vasey P, Twelves C, Kaye S, et al. Phase I clinical and pharmacokinetic study of PKI (HPMA copolymer doxorubicin): first member of a new class of chemotherapeutic agents: drug-polymer conjugates. Clin Cancer Res 1999; 5: 83-94.
6. 6. Caiolfa VR, Zamai M, Fiorino A, et al. Novel perspectives in topoisomerase-1 inhibitor-based chemotherapy of solid tumours: MAG-camptothecin conjugates. In: Proc 9th Int Symp on Recent Advances in Drug Delivery Systems 1999: 46-9.
7. 7. Kerr D, Seymour L, Boivin C, et al. Phase I clinical trial of HPMA copolymers bearing doxorubicin and galactosamine. In: Proc 3rd Int Symp on Polymer Therapeutics, London 1998: 23.
8. 8. Ten Bokkel Huniunk WW, Terwogt JM, Dubbelman R, et al. Phase I study of PNU166945, a polymer formulated paclitaxel. In: Proc 3rd Int Symp on Polymer Therapentics, London 1998: 12.
9. 9. Newkome GR, Moorefield CN, Vögtle F. Dendritic molecules. New York: VCH 1996: 1-261.
10. 10. Roy R. Recent developments in the rational design of multivalent glycoconjugates. Top Curr Chem 1997; 187: 241-74.
11. 11. Jansen JFGA, de Brabander-van den Berg EMM, Meijer EW, Encapsulation of guest molecules into a dendritic box, Science 1994; 266: 1226-9.
12. 125I-labelled PAMAM dendrimers in vivo. J Cont Rel 1999; in press.
13. 13. Gordon M, Hollander S. Review of platinum anticancer compounds. J Med 1993; 24: 209-65.
14. 14. Eastmen A, Schulte N, Sheibani N, Sorenson CN. Mechanisms of resistance to platinum drugs. In: Nicolini M, ed. Platinum and other metal coordination compounds in cancer chemotherapy. Boston, MA: Nijhoff 1988: 178-217.
15. 15. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy; mechanism of tumoritropic accumulation of proteins and the antitumour agent SMANCS. Cancer Res 1986; 6: 6387-92.
16. 16. Seymour LW, Ulbrich K, Styger PS, et al. Tumouritropism and anticancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma. Br J Cancer 1994; 70: 636-41.
17. 17. Duncan R, Evagorou EG, Buckley RG, Gianasi E, Wasil M, Wilson G. Comparative evaluation of novel polymer platinates. I. Synthesis, characterisation and in vitro properties. In: Proc Int Symp on Controlled Release of Bioactive Materials 1997; 24: 775-6.
18. 18. Ferruti P, Bignotti F, Ranucci E, et al. Synthesis and antitumour activity of platinum(II) complexes of novel functionalised poly(amidoamine)s. Macromol Chem Phys 1999; in press.
19. 19. Gianasi E, Wasil M, Evagorou EG, Keddle A, Wilson G. Duncan R. HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity. Eur J Cancer 1999; in press.
20. 20. Duncan R, Sat YN. Tumour targeting by enhanced permeability and retention (EPR) effect. Ann Oncol 1998; 9 (suppl 2): 39.
21. 21. Tomalia DA, Baker H, Dewald JR, et al. A new class of polymers - starburst-dendritic macromolecules. Polym J 1985; 17: 117-32.
22. 22. Schechter B, Pauzner R, Arnon R, Wilchek M. Cisplatinum(II) complexes of carboxymethyl-dextran as potential antitumour agents I. Preparation and characterization. Cancer Biochem Biophys 1986; 8: 277-87.
23. 23. Sgouras D, Duncan R. Methods for the evaluation of biocompatability of soluble synthetic polymers which have potential biomedical use: I - Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation of in vitro cytotoxicity. J Mater Sci: Mater Med 1990; 1: 67-8.
24. 24. Rose WC, Schurig JE, Huftalen JB, Bradner WT. Antitumor activity and toxicity of cisplatin analogs. Cancer Treat Rep 1982; 66: 135-46.
25. 25. Muggia FM, Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. Clin Cancer Res 1999; 5: 7-8.
26. 26. Harrap KR. Discovery of improved platinum analogues. In: Workman P, ed. New approaches in cancer pharmacology: drug design and development, vol II. European School of Oncology Monographs. Berlin: Springer-Verlag 1994: 23-37.
27. 27. Seymour LW, Miyamoto Y, Brereton M, et al. Influence of molecular size on passive tumour-accumulation of soluble macromolecular drug carriers. Eur J Cancer 1995; 5: 766-70.
28. 28. Barth RF, Adams DM, Soloway AH, Alam F, Darby MV. Boronated starburst-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. Bioconj Chem 1994; 5: 58-66.
29. 29. Yang WL, Barth RF, Adams DM, Soloway AH. Intratumoural delivery of boronated epidermal growth factor for neutron capture therapy of brain tumours. Cancer Res 1997; 57: 4333-9.
30. 30. Trail P, Willner D, Hellestrom KE. Site-directed delivery of anthracyclines for the treatment of cancer. Drug Dev Res 1995; 34: 196-209.
31. 31. Onetto N, LoBuglio A, Bookman M, et al. Tumour targeting therapy directed to the ley antigen. In: Pavlidis N, ed. Proc EORTC Early Drug Development Meeting. Greece: National Library of Greece 1995; 59: 7.